Reports for AMOXICILLIN
Ingredient
AMOXICILLIN
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
NOVAMOXIN | 250MG | TABLET (CHEWABLE) | Resolved | 2020-03-26 | 2020-07-09 | 109604 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-09-22 | 2024-02-14 | 169966 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2020-04-10 | 2020-04-23 | 111841 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2020-05-14 | 2020-06-04 | 115196 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2022-05-19 | 2022-07-01 | 160983 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Actual shortage | 2023-10-19 | 2024-03-18 | 207503 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2019-10-03 | 2020-04-02 | 95408 |
NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Resolved | 2019-10-03 | 2020-03-26 | 95411 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
AMOXI-CLAV | 500MG 125MG | TABLET | Discontinued | 2018-01-25 | 2018-01-25 | 37195 |
AMOXI-CLAV | 875MG 125MG | TABLET | Discontinued | 2018-04-26 | 2018-04-27 | 47253 |
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
AMOXICILLIN | 125MG | GRANULES FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4933 |
AMOXICILLIN | 125MG | GRANULES FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4939 |
PMS-AMOXICILLIN | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-07-13 | 2018-09-20 | 55729 |
AMOXICILLIN | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2017-06-06 | 2017-06-07 | 12028 |
AMOXICILLIN | 250MG | CAPSULE | Discontinued | 2018-06-12 | 2018-09-11 | 52192 |
AMOXICILLIN SUGAR-REDUCED GRANULES FOR ORAL SUSPENSION | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2017-06-06 | 2017-06-07 | 12022 |
AMOXICILLIN SUGAR-REDUCED GRANULES FOR ORAL SUSPENSION | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2017-06-06 | 2017-06-07 | 12025 |